Objectives The objective of this systematic review and meta-analysis was to estimate the
global prevalence of multi-drug resistant (MDR) Pseudomonas aeruginosa causing …

Background Antimicrobial-resistant (AMR) bacterial infection is a significant global threat to
the healthcare systems. Pseudomonas aeruginosa, the leading infectious agent in the …

Objectives Pseudomonas aeruginosa is known as a leading cause of nosocomial infections
worldwide. Antimicrobial resistance and biofilm production, as two main virulence factors of …

Background Aminoglycosides have been a cornerstone of the treatment of nosocomial
infections caused by Pseudomonas aeruginosa for over 80 years. However, escalating …

For the first time since 2015, the World Health Organization's (WHO) global Antimicrobial
Resistance and Use Surveillance (GLASS) featured both global reports for antimicrobial …

Antibiotic resistance occurs when microorganisms resist the drugs used against the infection
caused by them and neutralize their effects over time using various mechanisms. These …

Background. Carbapenems are the last‐line therapy for multidrug‐resistant (MDR) infections
caused by Enterobacterales, including those caused by Enterobacter species. However, the …

Resistant microorganisms such as Pseudomonas aeruginosa grow by develo** biofilms
in hospitals. We aimed to investigate the biofilm formation and the frequencies of biofilm …

Background: Drug resistance and virulence genes are two key factors for the colonization of
Pseudomonas aeruginosa in settings with high antibiotic pressure, such as hospitals, and …

Background Pseudomonas aeruginosa is a major cause of healthcare-associated infections
(HAIs), particularly in immunocompromised patients, leading to high morbidity and mortality …